NCT03365219

Brief Summary

Post cesarean section surgical site infection (SSI) is a common complication that can affect patient recovery and overall outcome. Several approaches have been studied to improve SSI rates such as timing of antibiotic administration and skin preparation. Alexis retractors have been suggested as a reasonable option to decrease SSI. However, to date there is only one randomized controlled study assessing its efficacy. The aim of this study is to whether Alexis wound retractors are beneficial in preventing cesarean section SSI.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
564

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2010

Typical duration for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2010

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2013

Completed
1.7 years until next milestone

First Submitted

Initial submission to the registry

June 9, 2015

Completed
2.5 years until next milestone

First Posted

Study publicly available on registry

December 7, 2017

Completed
Last Updated

October 19, 2018

Status Verified

May 1, 2018

Enrollment Period

3 years

First QC Date

June 9, 2015

Last Update Submit

October 17, 2018

Conditions

Keywords

Surgical Site InfectionCesarean delivery infection

Outcome Measures

Primary Outcomes (1)

  • Surgical Site Infection

    Assessed as present or absent. Defined as the development of wound infection, seroma, or other wound disruption in patients who underwent a cesarean delivery

    Time of surgery up to 14 post operative days

Secondary Outcomes (4)

  • Postoperative pain

    Time of surgery up to 14 post operative days

  • Estimated blood loss

    intraoperative assessment

  • Uterus exteriorization

    intraoperative assessment

  • Total operative time

    intraoperative assessment

Other Outcomes (5)

  • Apgar scores

    Assessed in every infant at 1 minute and 5 minutes of life

  • Gestational age at time of delivery

    at time of delivery

  • Infant weight

    At time of delivery

  • +2 more other outcomes

Study Arms (2)

Alexis Retractor

EXPERIMENTAL

This group received an Alexis O-Ring Wound Retractor during cesarean delivery.

Device: Alexis O-Ring Wound Retractor

Standard Surgical Retractors

ACTIVE COMPARATOR

This group received routine hand-held metal retractors as needed by the surgical team during cesarean delivery.

Other: Standard Surgical Retractors

Interventions

A flexible self-retaining plastic Alexis retractor was used in place of standard surgical retractors.

Alexis Retractor

Routine hand-held metal retractors as needed by the surgical team

Standard Surgical Retractors

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • maternal age of at least 18 years
  • a gestational age of at least 24 0/7 wks by best obstetric estimate
  • a viable gestation
  • a non-emergent cesarean delivery
  • a planned transverse skin incision
  • Deliveries included: primary cesarean for failed induction, maternal request, or other obstetric indications; and repeat cesarean deliveries that were elective or had obstetric indications (such as spontaneous labor in a subject with a term gestation and with history of 2 or more prior cesarean deliveries)

You may not qualify if:

  • chorioamnionitis
  • chronic corticosteroid therapy
  • prior abdominal vertical skin incision scar or planned vertical incision
  • history of a prior wound infection or separation
  • planned cesarean hysterectomy
  • maternal or fetal complications requiring an emergent delivery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (12)

  • Menacker F, Hamilton BE. Recent trends in cesarean delivery in the United States. NCHS Data Brief. 2010 Mar;(35):1-8.

    PMID: 20334736BACKGROUND
  • Kirkland KB, Briggs JP, Trivette SL, Wilkinson WE, Sexton DJ. The impact of surgical-site infections in the 1990s: attributable mortality, excess length of hospitalization, and extra costs. Infect Control Hosp Epidemiol. 1999 Nov;20(11):725-30. doi: 10.1086/501572.

    PMID: 10580621BACKGROUND
  • Stone PW, Braccia D, Larson E. Systematic review of economic analyses of health care-associated infections. Am J Infect Control. 2005 Nov;33(9):501-9. doi: 10.1016/j.ajic.2005.04.246.

    PMID: 16260325BACKGROUND
  • Moir-Bussy B, Hutton R, Thompson J. Wound infection after caesarean section. Nurs Times. 1985 Jun 5-11;81(23):suppl 13-4. No abstract available.

    PMID: 3847906BACKGROUND
  • Rauk PN. Educational intervention, revised instrument sterilization methods, and comprehensive preoperative skin preparation protocol reduce cesarean section surgical site infections. Am J Infect Control. 2010 May;38(4):319-23. doi: 10.1016/j.ajic.2009.10.004. Epub 2010 Feb 19.

    PMID: 20171756BACKGROUND
  • Schneid-Kofman N, Sheiner E, Levy A, Holcberg G. Risk factors for wound infection following cesarean deliveries. Int J Gynaecol Obstet. 2005 Jul;90(1):10-5. doi: 10.1016/j.ijgo.2005.03.020.

    PMID: 15913620BACKGROUND
  • Tran TS, Jamulitrat S, Chongsuvivatwong V, Geater A. Risk factors for postcesarean surgical site infection. Obstet Gynecol. 2000 Mar;95(3):367-71. doi: 10.1016/s0029-7844(99)00540-2.

    PMID: 10711546BACKGROUND
  • Weiss JL, Malone FD, Emig D, Ball RH, Nyberg DA, Comstock CH, Saade G, Eddleman K, Carter SM, Craigo SD, Carr SR, D'Alton ME; FASTER Research Consortium. Obesity, obstetric complications and cesarean delivery rate--a population-based screening study. Am J Obstet Gynecol. 2004 Apr;190(4):1091-7. doi: 10.1016/j.ajog.2003.09.058.

    PMID: 15118648BACKGROUND
  • Cedergren MI. Maternal morbid obesity and the risk of adverse pregnancy outcome. Obstet Gynecol. 2004 Feb;103(2):219-24. doi: 10.1097/01.AOG.0000107291.46159.00.

    PMID: 14754687BACKGROUND
  • ACOG Practice Bulletin No. 120: Use of prophylactic antibiotics in labor and delivery. Obstet Gynecol. 2011 Jun;117(6):1472-1483. doi: 10.1097/AOG.0b013e3182238c31. No abstract available.

    PMID: 21606770BACKGROUND
  • Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guideline for Prevention of Surgical Site Infection, 1999. Centers for Disease Control and Prevention (CDC) Hospital Infection Control Practices Advisory Committee. Am J Infect Control. 1999 Apr;27(2):97-132; quiz 133-4; discussion 96.

    PMID: 10196487BACKGROUND
  • Cheng KP, Roslani AC, Sehha N, Kueh JH, Law CW, Chong HY, Arumugam K. ALEXIS O-Ring wound retractor vs conventional wound protection for the prevention of surgical site infections in colorectal resections(1). Colorectal Dis. 2012 Jun;14(6):e346-51. doi: 10.1111/j.1463-1318.2012.02943.x.

MeSH Terms

Conditions

Surgical Wound Infection

Condition Hierarchy (Ancestors)

Wound InfectionInfectionsPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Gayle L Olson, MD

    University of Texas Medical Branch in Galveston

    PRINCIPAL INVESTIGATOR
  • George Saade, MD

    University of Texas Medical Branch in Galveston

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 9, 2015

First Posted

December 7, 2017

Study Start

October 1, 2010

Primary Completion

October 1, 2013

Study Completion

October 1, 2013

Last Updated

October 19, 2018

Record last verified: 2018-05

Data Sharing

IPD Sharing
Will not share